Cardiovascular diseases: different and misunderstood symptoms for women?
All the news from Servier Group
3 reasons to read our Integrated Annual Report 2022-2023
Focus on Blue March: Our commitment to patients with colorectal cancer
Therapeutic innovation to meet the challenge of rare diseases
Gaining perspective on therapeutic adherence through a Servier study in cardiology
Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition
World Cancer Day: Innovating in oncology to serve patient needs
Servier among the top 3 most innovative oncology companies in France!
Poland, India, and Germany: Our teams mobilized for patients!